The operating group also re-affirmed AMP's prior position that some extremely high-risk tests do require pre-intro review by an authorized reviewer and outlined the types of LDPs to which this would apply. To download a PDF of this article, visit: To see other AMP position letters and statements, visit:.. AMP proposes fresh, service-oriented terminology for high quality laboratory testing Proposes new, service-oriented terminology – – Laboratory Developed Procedures The Association for Molecular Pathology released a particular content in the January 2014 problem of the Journal of Molecular Diagnostics titled Revisiting Oversight and Regulation of Molecular-Based Laboratory-Developed Testing .This acquisition, and also the others we’ve announced this season all contribute to attaining that long-term goal, said Mr. White. With this transaction Solvay Pharmaceuticals has discovered a new strong home, within a reputable company with a solid and committed position in the industry, comments Christian Jourquin, ceo, Solvay. Solvay’s pharmaceutical portfolio complements Abbott’s presence and expertise in specialty markets such as for example cardiovascular disease, neuroscience and gastroenterology. Solvay also offers products to treat men’s and women’s hormonal health, and exocrine pancreatic insufficiency , which is associated with several underlying circumstances including cystic fibrosis and chronic pancreatitis. The acquisition also includes Solvay’s vaccines business, that may provide Abbott entry in to the growing global vaccines marketplace.